Becton Dickinson (BDX) Net Income towards Common Stockholders (2009 - 2026)

Becton Dickinson (BDX) reported Net Income towards Common Stockholders of -$274.0 million for Q1 2026, down 282.67% year-over-year from $150.0 million in Q1 2025, and down 171.73% quarter-over-quarter from $382.0 million in Q4 2025.

Becton Dickinson (BDX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has 18 years of Net Income towards Common Stockholders data on file, last reported at -$274.0 million in Q1 2026.

  • Net Income towards Common Stockholders for Q1 2026 came in at -$274.0 million, down 282.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 12.31% YoY), and the FY2025 annual result was $1.7 billion, down 1.58% from the prior year.
  • Net Income towards Common Stockholders slipped to -$274.0 million in Q1 2026 per BDX's latest filing, from $382.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $574.0 million in Q2 2025 and troughed at -$274.0 million in Q1 2026.
  • A 5-year average of $340.6 million and a median of $392.0 million in 2023 frame the typical range for Net Income towards Common Stockholders.
  • The sharpest annual moves came in 2024 and 2026: Net Income towards Common Stockholders surged 270.37% in 2024, then tumbled 282.67% in 2026.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $486.0 million in 2022, then sank by 42.18% to $281.0 million in 2023, then grew by 7.83% to $303.0 million in 2024, then increased by 26.07% to $382.0 million in 2025, then tumbled by 171.73% to -$274.0 million in 2026.
  • Business Quant data shows BDX's Net Income towards Common Stockholders at -$274.0 million in Q1 2026, $382.0 million in Q4 2025, and $493.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -274.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 239.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 398.73 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 135.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 13.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -77.90 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 112.77 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 2.00 Mn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn 72.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -274.00 Mn
Dec 31, 2025 382.00 Mn
Sep 30, 2025 493.00 Mn
Jun 30, 2025 574.00 Mn
Mar 31, 2025 150.00 Mn
Dec 31, 2024 303.00 Mn
Sep 30, 2024 400.00 Mn
Jun 30, 2024 487.00 Mn
Mar 31, 2024 537.00 Mn
Dec 31, 2023 281.00 Mn
Sep 30, 2023 108.00 Mn
Jun 30, 2023 392.00 Mn
Mar 31, 2023 438.00 Mn
Dec 31, 2022 486.00 Mn
Sep 30, 2022 265.00 Mn
Jun 30, 2022 338.00 Mn
Mar 31, 2022 431.00 Mn
Dec 31, 2021 655.00 Mn
Sep 30, 2021 242.00 Mn
Jun 30, 2021 502.00 Mn